Glycobiology of Lung Inflammatory Diseases (Programs of Excellence in Glycosciences) Funded by: The National Heart, Lung, and Blood Institute (NHLBI); Grant #: P01HL107151

Shared Resources Core - Carbohydrate Synthesis
Specific Aims:
• Produce large scale quantities of advanced intermediates required for the production of targeted sialoside ligands.
• Produce sialoside ligands of siglecs to support projects of the Lung Inflammatory Disease (LID-PEG) program.

Compounds also available to the scientific community. It is expected that the requestor pay for shipping costs, plus ($xxx.xx per mg) to cover other costs associated with producing the compounds and arranging for shipment.

For more information, please contact the Core Director, Dr. Corwin Nycholat (email: nycholat@scripps.edu).



Sialoside ligands intermediates in stock (green) or available upon request ( yellow)
Glycan No.	Structure	Azide	Amine	Biotinylated	PAA (1 MDa)	(PEG)-Lipid	Lipid
1		1 mg	1 mg	50 ug	50 ug	1mg	1mg
2		1 mg	1 mg	50 ug	50 ug	1mg	1mg
3		NA	1 mg	50 ug	50 ug	1mg	1mg
4		NA	1 mg	50 ug	50 ug	1mg	1mg
5		1 mg	1 mg	50 ug	50 ug	1mg	1mg
6		1 mg	1 mg	50 ug	50 ug	1mg	1mg

Paulson Laboratory      Created by: Anna